Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.038595238095238 0.0547619047619049
Stock impact report

XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Study

XBiotech Inc. (XBIT)  More Company Research Source: GlobeNewswire
Last xbiotech inc. earnings: 8/9 03:01 pm Check Earnings Report
US:NASDAQ Investor Relations: xbiotech.com/about/investors.html
PDF AUSTIN, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today enrollment of the final patient into its Phase I study1 evaluating bermekimab in patients with advanced pancreatic adenocarcinoma and cachexia. The study is being conducted and led by principal investigator Andrew Hendifar, M.D., Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai Medical Center2.  A total of 18 patients are enrolled in the study. 1 NCT032077242 This research was partially supported through an external research grant from the US marketer of the chemotherapy product. The purpose of the study is to assess the safety and tolerability of bermekimab in combination with chemotherapy.  The study will also assess progression-free survival and overall survival of patients, as well as evaluate the relationship between treatment tolerance and patient functional status. Various health-related secondary measures, in [Read more]
Impact snapshot Event time: XBIT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
XBIT alerts
from News Quantified
Opt-in for
XBIT alerts

from News Quantified
Opt-in for
XBIT alerts

from News Quantified